- Home
- CISS vs GCTK Comparison
CISS vs GCTK Comparison
Compare CISS & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- GCTK
- Stock Information
- Founded
- CISS 2022
- GCTK 2001
- Country
- CISS Greece
- GCTK United States
- Employees
- CISS N/A
- GCTK N/A
- Industry
- CISS Marine Transportation
- GCTK Medical/Dental Instruments
- Sector
- CISS Consumer Discretionary
- GCTK Health Care
- Exchange
- CISS Nasdaq
- GCTK Nasdaq
- Market Cap
- CISS 5.3M
- GCTK 5.9M
- IPO Year
- CISS N/A
- GCTK N/A
- Fundamental
- Price
- CISS $1.69
- GCTK $5.02
- Analyst Decision
- CISS
- GCTK
- Analyst Count
- CISS 0
- GCTK 0
- Target Price
- CISS N/A
- GCTK N/A
- AVG Volume (30 Days)
- CISS 114.8K
- GCTK 34.6K
- Earning Date
- CISS 11-18-2025
- GCTK 11-13-2025
- Dividend Yield
- CISS N/A
- GCTK N/A
- EPS Growth
- CISS N/A
- GCTK N/A
- EPS
- CISS N/A
- GCTK N/A
- Revenue
- CISS $33,613,149.00
- GCTK N/A
- Revenue This Year
- CISS N/A
- GCTK N/A
- Revenue Next Year
- CISS N/A
- GCTK N/A
- P/E Ratio
- CISS $0.29
- GCTK N/A
- Revenue Growth
- CISS N/A
- GCTK N/A
- 52 Week Low
- CISS $1.57
- GCTK $4.22
- 52 Week High
- CISS $17.25
- GCTK $468.00
- Technical
- Relative Strength Index (RSI)
- CISS 31.49
- GCTK 34.46
- Support Level
- CISS $1.57
- GCTK $5.39
- Resistance Level
- CISS $2.02
- GCTK $6.04
- Average True Range (ATR)
- CISS 0.14
- GCTK 0.27
- MACD
- CISS -0.03
- GCTK -0.11
- Stochastic Oscillator
- CISS 9.45
- GCTK 4.21
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.